XML 16 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:    
Net loss $ (628) $ (664)
Adjustment to reconcile net loss to net cash (used in) provided by operating activities    
Amortization of loan discount, loan commitment and deferred financing fees 150 210
Depreciation expense 57 37
Earnings from unconsolidated joint venture, net of distributions 4 18
Stock compensation 86 32
Impairment charges 558 0
Changes in operating assets and liabilities:    
Trade receivables (5,216) 469
Real estate inventories 1,157 524
Other assets (655) 550
Accrued interest 592 253
Accounts payable and accrued liabilities 3,840 (754)
Income taxes payable 6 0
Net cash (used in) provided by operating activities (49) 675
Cash flows from investing activities:    
Purchase of fixed assets (46) (1)
Principal received on note receivable 9 9
Net cash (used in) provided by investing activities (37) 8
Cash flows from financing activities:    
Proceeds from notes payable 2,853 5,499
Payments on notes payable (3,458) (5,981)
Loan financing costs (57) (71)
Distributions to non-controlling interests 0 (1,908)
Net cash used in financing activities (662) (2,461)
Net decrease in cash, restricted cash, and cash equivalents (748) (1,778)
Cash, restricted cash, and cash equivalents, beginning of period 2,947 6,999
Cash, restricted cash, and cash equivalents, end of period 2,199 5,221
Supplemental cash flow information:    
Interest paid, net of interest capitalized 605 243
Supplemental disclosure for non-cash activity:    
Seller's note payable 0 115
Accrued liability settled through issuance of stock 0 32
Increase in Series B preferred stock value in connection with dividends paid in-kind 0 24
Extinguishment of Series B Preferred Stock $ 0 $ 1,011